Epigenetic biomarker screening by FLIM-FRET for combination therapy in ER+ breast cancer

Title
Epigenetic biomarker screening by FLIM-FRET for combination therapy in ER+ breast cancer
Authors
Keywords
Fluorescence lifetime, Förster resonance energy transfer, Epigenetic markers, Combination therapy, Breast cancer, Histone acetylation, Anacardic acid
Journal
Clinical Epigenetics
Volume 11, Issue 1, Pages -
Publisher
Springer Nature
Online
2019-01-30
DOI
10.1186/s13148-019-0620-6

Ask authors/readers for more resources

Reprint

Contact the author

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started